Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04349501 · ClinicalTrials.gov registry record · NA

Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)

A NA study of Prostate Cancer, sponsored by University of California, San Diego.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04349501 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 100 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04349501, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Adult male patients with high-risk, localized prostate cancer and planning to undergo radiation therapy (RT) with androgen deprivation therapy (ADT) will undergo an advanced Magnetic Resonance Imaging (MRI) examination called Restriction Spectrum Imaging (RSI-MRI) to evaluate whether RSI-MRI can predict treatment response.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Restriction Spectrum Imaging Magnetic Resonance Imaging

Study Locations (1)

California

  • UCSD Moores Cancer Center - La Jolla

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-12-29
Est. Completion 2026-12
Phase NA

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04349501

The ClinicalTrials.gov registry entry for NCT04349501 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (84% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Restriction Spectrum Imaging Magnetic Resonance Imaging is the first listed.

NCT04349501 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04349501 about?

NCT04349501 is a clinical study titled "Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)". Adult male patients with high-risk, localized prostate cancer and planning to undergo radiation therapy (RT) with androgen deprivation therapy (ADT) will undergo an advanced Magnetic Resonance Imaging (MRI) examination called Restriction Spectrum Imaging (RSI-MRI) to evaluate whether RSI-MRI can pre...

What is the current status of trial NCT04349501?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-12-29. Estimated completion is 2026-12.

What conditions does trial NCT04349501 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04349501?

The interventions under investigation include: Restriction Spectrum Imaging Magnetic Resonance Imaging (OTHER).

Who is sponsoring clinical trial NCT04349501?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04349501 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.